Lithium- Sensitive Store-Operated Ca2+ Entry in the Regulation of FGF23 Release
Background/Aims: Lithium, a widely used drug for the treatment of mood disorders, has previously been shown to stimulate the release of fibroblast growth factor FGF23, a powerful regulator of 1,25(OH)2D3 formation and mineral metabolism. The cellular mechanisms involved have remained elusive. Lithiu...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-12-01
|
Series: | Neurosignals |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/442602 |